Salt la conținut
Global sound
Base to Base Biotech

Base to Base Biotech

Base to Base biotech podcast 71: The IgA/CD89 axis

· 27 min · Episodul 71

Note de episod

This week, we have a conversation Paweł Szczepański, CEO of JJP Biologics about specially-built antibodies to tackle autoimmune diseases and cancer.
JJP Biologics
JJP Biologics is a clinical-stage biotech that leverages its in-depth understanding of immune pathway science in autoimmune diseases and cancer. Starting from deep mechanistic insights, JJPBio engineers antibodies that are built-to-order, designed to restore immune balance and deliver better disease control for patients with significant unmet need, because we believe that we can do better for patients.
JJPBio is the first company…

Site: rss.com

Live, ultima oră: 10.070 melodii pe 4.118 posturi din 93 țări

Descoperă lumea prin radio

Mai multe moduri de a descoperi (7)

Ai auzit ceva frumos? Salvează-l sau deschide-l direct în Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
WDVX RadioContinuă să asculți